Cell and gene therapies hold promise for treating various diseases, but technology to deliver targeted medicines to specific cells is lacking. Engineered cells produce multifunctional particles, designed to carry cargo and target specific cell types. In experiments, the particles successfully delivered gene editing cargo to T cells.
Read more https://www.sciencedaily.com/releases/2023/11/231127132232.htm